丙型肝炎病毒 (HCV) 是一种正链 RNA 病毒,属于黄病毒科 (Flaviviridae) 中的丙型肝炎病毒 (Hepacivirus) 属。HCV 至少分为 6 种基因型 (gt),其易错聚合酶导致超过 50 种亚型。编码 HCV 多聚蛋白的长开放阅读框由宿主和病毒蛋白酶加工,产生三种结构蛋白(衣壳蛋白核心和包膜糖蛋白 E1 和 E2)和七种非结构 (NS) 蛋白(p7、NS2、NS3、NS4A、NS4B、NS5A 和 NS5B)。NS2 和 p7 对病毒组装至关重要,但对 RNA 复制并非如此,而 NS3 至 NS5B 参与膜相关 RNA 复制酶复合物 (RC)。NS3 蛋白由丝氨酸蛋白酶和 RNA 解旋酶/核苷三磷酸酶 (NTPase) 组成,NS4A 是 NS3 丝氨酸蛋白酶的辅因子,NS5B 是 RNA 依赖性 RNA 聚合酶,NS5A 被认为在 HCV 生命周期的多个步骤中发挥关键作用。NS5A 抑制剂在给予 HCV 感染细胞后不久即可快速抑制病毒的传染性。
HCV 蛋白 NS5A 通过抑制 Kv2.1 功能,从而阻止肝细胞死亡,防止导致细胞凋亡的细胞内钾离子流失。
HCV RNA 依赖性 RNA 聚合酶 (RdRp) 长期以来一直是抗病毒开发的主要目标,因为它在病毒复制中起着关键作用,并且缺乏哺乳动物同源酶。
蛋白酶是 lucidone 和 α 干扰素的组合,抑制剂 Telaprevir、NS5A 抑制剂 BMS-790052 或 NS5B 聚合酶抑制剂 PSI-7977 可协同抑制 HCV RNA 复制。
Hepatitis C virus (HCV) is a positive-strand RNA virus grouped in the genus Hepacivirus within the family Flaviviridae. HCV is classified into at least 6 genotypes (gt), and its error-prone polymerase leads to more than 50 subtypes. The long open reading frame, which encodes the HCV polyprotein, is processed by host and viral proteases and gives rise to three structural proteins (the capsid protein core and envelope glycoproteins E1 and E2) and seven nonstructural (NS) proteins (p7, NS2, NS3, NS4A, NS4B, NS5A, and NS5B). NS2 and p7 are essential for virus assembly but not RNA replication, whereas NS3 to NS5B are involved in a membrane-associated RNA replicase complex (RC). The NS3 protein is composed of a serine protease and an RNA helicase/nucleoside triphosphatase (NTPase), NS4A serves as a cofactor for NS3 serine protease, NS5B is the RNA-dependent RNA polymerase, and NS5A is considered to play key roles in multiple steps of the HCV life cycle.NS5A inhibitors exhibit a rapid inhibition of virus infectivity shortly after administration to HCV-infected cells.
The HCV protein NS5A prevents the apoptosis-enabling loss of intracellular potassium by inhibiting Kv2.1 function and thus blocking hepatocyte cell death.
The HCV RNA-dependent RNA polymerase (RdRp) has long been a prime target for antiviral development because of its critical role in viral replication and the absence of a mammalian homologous enzyme.
The combination of lucidone and alpha interferon, the protease inhibitor Telaprevir, the NS5A inhibitor BMS-790052, or the NS5B polymerase inhibitor PSI-7977, synergistically suppresses HCV RNA replication.
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号